Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Adrenal Gland Neoplasms 4 Pheochromocytoma 2 Adrenal incidentaloma 2 Urinary Bladder Neoplasms 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Cushing Syndrome 1 Carcinoma, Renal Cell 1 Adrenocortical Carcinoma 1 Adrenocortical Adenoma 1

Interventions

Mitotane 7 Cisplatin 6 pembrolizumab 5 Etoposide 3 Doxorubicin 3 camrelizumab 2 apatinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cytoreduction Surgical Procedures 2 sodium thiosulfate 1 iodophenyl metomidate 1 fludarabine phosphate 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Suramin 1 Sunitinib 1 Streptozocin 1 Sorafenib 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Megestrol Acetate 1 Lymph Node Excision 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adrenocortical Carcinoma × Adrenalectomy × Clear all

NCT05763524 2023-03-20

LACC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡